Pembrolizumab plus Trastuzumab und Chemotherapie
Crossref DOI link: https://doi.org/10.1007/s15036-024-3660-5
Published Online: 2024-02-16
Published Print: 2024-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Horr, Fabienne
Quante, Michael
Text and Data Mining valid from 2024-02-01
Version of Record valid from 2024-02-01
Article History
First Online: 16 February 2024